444583-56-6

Upstream product

• 444583-55-5 C₂₅H₂₉ClN₂O₅ 

Downstream Products

• 900535-64-0 1-({1-(4-chloro-benzyl)-2-[4-(1-cyclohexylmethyl-2-morpholin-4-yl-ethyl)-piperazin-1-yl]-2-oxo-ethylcarbamoyl}-methyl)-1,3-dihydro-isoindole-2-carboxylic acid tert-butyl ester 
• 900535-72-0 1-({1-(4-chloro-benzyl)-2-[4-(2-cyclohexyl-1-cyclohexylmethyl-ethyl)-piperazin-1-yl]-2-oxo-ethylcarbamoyl}-methyl)-1,3-dihydro-isoindole-2-carboxylic acid tert-butyl ester 
• 900535-69-5 1-[(1-(4-chloro-benzyl)-2-{4-[1-cyclohexyl-2-(2,5-dioxo-pyrrolidin-1-yl)-ethyl]-piperazin-1-yl}-2-oxo-ethylcarbamoyl)-methyl]-1,3-dihydro-isoindole-2-carboxylic acid tert-butyl ester 
• 569653-81-2 1-({1-(4-chloro-benzyl)-2-[4-(4-cyclohexylmethyl-1-methyl-piperidin-4-yl)-piperazin-1-yl]-2-oxo-ethylcarbamoyl}-methyl)-1,3-dihydro-isoindole-2-carboxylic acid tert-butyl ester 

Relevant academic research and scientific papers

Piperazine- and piperidine-derivatives as melanocortin receptor agonists

The present invention relates to melanocortin receptor agonists of formula I, which is useful in the treatment of obesity, diabetes and male and/or female sexual dysfunction.